ArticleCell discovery2022

A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration.

Huan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.